Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea

Emerging Infectious Diseases

Volumn 21, Issue 6, 2015, Pages 1088-1089

  Cho, Sun Young ^a   Huh, Hee Jae ^a   Baek, Jin Yang ^b   Chung, Na Yeon ^b   Ryu, Jae Geum ^a   Ki, Chang Seok ^a   Chung, Doo Ryeon ^b   Lee, Nam Yong ^a   Song, Jae Hoon ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 5; OXACILLINASE 181 CARBAPENEMASE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE;

ACUTE RESPIRATORY FAILURE; AGED; ANTIBIOTIC SENSITIVITY; ASPIRATION PNEUMONIA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BROTH DILUTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CASE REPORT; DNA SEQUENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY FAILURE; SEPTIC SHOCK; TRACHEAL ASPIRATION PROCEDURE; BIOSYNTHESIS; FATALITY; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; SOUTH KOREA; TREATMENT OUTCOME;

AGED; BACTERIAL PROTEINS; BETA-LACTAMASES; FATAL OUTCOME; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84929410700     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2106.150048     Document Type: Letter

References (10)

1. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18:413-31. http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791-8. http://dx.doi.org/10.3201/eid1710.110655
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. M100-S24. Wayne (PA): The Institute; 2014.
4. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical Breakpoints version 3.0. EUCAST; 2013 [cited 2015 Jan 8]. http://www.eucast.org/clinical_breakpoints/
5. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178-82. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005
6. Matushek MG, Bonten MJ, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol. 1996;34:2598-600.
7. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55:5952-4. http://dx.doi.org/10.1128/AAC.05108-11
8. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67:1597-606. http://dx.doi.org/10.1093/jac/dks121
9. Zowawi HM, Sartor AL, Balkhy HH, Walsh TR, Al Johani SM, AlJindan RY, et al. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers. Antimicrob Agents Chemother. 2014;58:3085-90. http://dx.doi.org/10.1128/AAC.02050-13
10. Sonnevend A, Al Baloushi A, Ghazawi A, Hashmey R, Girgis S, Hamadeh MB, et al. Emergence and spread of NDM-1 producer Enterobacteriaceae with contribution of IncX3 plasmids in the United Arab Emirates. J Med Microbiol. 2013;62:1044-50. http://dx.doi.org/10.1099/jmm.0.059014-0